Literature DB >> 20132230

Interleukin-2 inhibits polarization to T helper type 1 cells and prevents mouse acute graft-versus-host disease through up-regulating suppressors of cytokine signalling-3 expression of naive CD4+ T cells.

J Zhao1, T Zhang, H He, Y Xie.   

Abstract

T helper type 1 (Th1)-type polarization plays a critical role in the pathophysiology of acute graft-versus-host disease (aGVHD). The differentiation of T cells into this subtype is dictated by the nature of the donor naive CD4(+) T cell-host antigen presenting cell (APC) interaction. Suppressors of cytokine signalling (SOCS) are a family of molecules that act as negative regulators for cytokine signalling, which regulate the negative cytokine signalling pathway through inhibiting the cytokine-induced Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway. Studies have shown that SOCS proteins are key physiological regulators of both innate and adaptive immunity. These molecules are essential for T cell development and differentiation. SOCS-3 can inhibit polarization to Th1 and contribute to polarization to Th2. In this study, we found that interleukin (IL)-2 pre-incubation of C57BL/6 naive CD4(+) T cells could up-regulate the expression of SOCS-3. Naive CD4(+) T cells constitutively expressed low levels of SOCS-3 mRNA. SOCS-3 mRNA began to rise after 4 h, and reached peak level at 6 h. At 8 h it began to decrease. High expression of SOCS-3 mRNA induced by IL-2 could inhibit the proliferation of naive CD4(+) T cells following stimulation with allogeneic antigen. IL-2-induced high SOCS-3 expression in naive CD4(+) T cells could inhibit polarization to Th1 with stimulation of allogeneic antigens. We have demonstrated that IL-2-induced high SOCS-3 expression in naive CD4(+) T cells could reduce the incidence of aGVHD between major histocompatibility complex (MHC) completely mismatched donor and host when high SOCS3 expression of CD4(+)T cells encounter allogeneic antigen in time. These results show that IL-2-induced high SOCS-3 expression can inhibit aGVHD through inhibiting proliferation and polarization to Th1 with the stimulation of allogeneic antigen.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20132230      PMCID: PMC2883120          DOI: 10.1111/j.1365-2249.2010.04089.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  42 in total

Review 1.  Haematopoietic cell transplantation as immunotherapy.

Authors:  F R Appelbaum
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

Review 2.  Suppressors of cytokine signalling (SOCS) in the immune system.

Authors:  Warren S Alexander
Journal:  Nat Rev Immunol       Date:  2002-06       Impact factor: 53.106

3.  A regulatory role for suppressor of cytokine signaling-1 in T(h) polarization in vivo.

Authors:  Minoru Fujimoto; Hiroko Tsutsui; Shizue Yumikura-Futatsugi; Haruyasu Ueda; Ouyang Xingshou; Tatsuo Abe; Ichiro Kawase; Kenji Nakanishi; Tadamitsu Kishimoto; Tetsuji Naka
Journal:  Int Immunol       Date:  2002-11       Impact factor: 4.823

Review 4.  Advances in interleukin 2 receptor targeted treatment.

Authors:  J C Morris; T A Waldmann
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

5.  Induction of ocular inflammation by T-helper lymphocytes type 2.

Authors:  Stephen J Kim; Meifen Zhang; Barbara P Vistica; Chi-Chao Chan; De-Fen Shen; Eric F Wawrousek; Igal Gery
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-03       Impact factor: 4.799

6.  Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance.

Authors:  Charles E Egwuagu; Cheng-Rong Yu; Meifen Zhang; Rashid M Mahdi; Stephen J Kim; Igal Gery
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

7.  Acute graft-versus-host disease does not require alloantigen expression on host epithelium.

Authors:  Takanori Teshima; Rainer Ordemann; Pavan Reddy; Svetlana Gagin; Chen Liu; Kenneth R Cooke; James L M Ferrara
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

Review 8.  Advances in the understanding of acute graft-versus-host disease.

Authors:  Edward S Morris; Geoffrey R Hill
Journal:  Br J Haematol       Date:  2007-04       Impact factor: 6.998

9.  Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.

Authors:  Emmanuel Zorn; Kathy S Wang; Ephraim P Hochberg; Christine Canning; Edwin P Alyea; Robert J Soiffer; Jerome Ritz
Journal:  Clin Cancer Res       Date:  2002-07       Impact factor: 12.531

Review 10.  SOCS proteins, cytokine signalling and immune regulation.

Authors:  Akihiko Yoshimura; Tetsuji Naka; Masato Kubo
Journal:  Nat Rev Immunol       Date:  2007-05-18       Impact factor: 53.106

View more
  4 in total

Review 1.  Regulation of CD4+ T-cell polarization by suppressor of cytokine signalling proteins.

Authors:  Camille A Knosp; James A Johnston
Journal:  Immunology       Date:  2012-02       Impact factor: 7.397

2.  Out-of-Sequence Signal 3 Paralyzes Primary CD4(+) T-Cell-Dependent Immunity.

Authors:  Gail D Sckisel; Myriam N Bouchlaka; Arta M Monjazeb; Marka Crittenden; Brendan D Curti; Danice E C Wilkins; Kory A Alderson; Can M Sungur; Erik Ames; Annie Mirsoian; Abhinav Reddy; Warren Alexander; Athena Soulika; Bruce R Blazar; Dan L Longo; Robert H Wiltrout; William J Murphy
Journal:  Immunity       Date:  2015-07-28       Impact factor: 31.745

3.  Interleukin-12 (IL-12p70) Promotes Induction of Highly Potent Th1-Like CD4(+)CD25(+) T Regulatory Cells That Inhibit Allograft Rejection in Unmodified Recipients.

Authors:  Nirupama Darshan Verma; Bruce Milne Hall; Karren Michelle Plain; Catherine M Robinson; Rochelle Boyd; Giang T Tran; Chuanmin Wang; G Alex Bishop; Suzanne J Hodgkinson
Journal:  Front Immunol       Date:  2014-05-09       Impact factor: 7.561

4.  Protection of Mice from Acute Graft-versus-Host Disease Requires CD28 Co-stimulation on Donor CD4+ Foxp3+ Regulatory T Cells.

Authors:  Anna Uri; Sandra Werner; Fred Lühder; Thomas Hünig; Thomas Kerkau; Niklas Beyersdorf
Journal:  Front Immunol       Date:  2017-06-23       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.